141 related articles for article (PubMed ID: 27882102)
1. Inhibition of antiviral drug cidofovir on proliferation of human papillomavirus-infected cervical cancer cells.
Yang J; Dai LX; Chen M; Li B; Ding N; Li G; Liu YQ; Li MY; Wang BN; Shi XL; Tan HB
Exp Ther Med; 2016 Nov; 12(5):2965-2973. PubMed ID: 27882102
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antiproliferative effects of alkoxyalkyl esters of cidofovir in human cervical cancer cells in vitro.
Hostetler KY; Rought S; Aldern KA; Trahan J; Beadle JR; Corbeil J
Mol Cancer Ther; 2006 Jan; 5(1):156-9. PubMed ID: 16432174
[TBL] [Abstract][Full Text] [Related]
3. Cidofovir selectivity is based on the different response of normal and cancer cells to DNA damage.
De Schutter T; Andrei G; Topalis D; Naesens L; Snoeck R
BMC Med Genomics; 2013 May; 6():18. PubMed ID: 23702334
[TBL] [Abstract][Full Text] [Related]
4. Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populations.
Wen X; Li D; Zhang Y; Liu S; Ghali L; Iles RK
Anticancer Drugs; 2012 Mar; 23(3):280-7. PubMed ID: 22245994
[TBL] [Abstract][Full Text] [Related]
5. Cidofovir in the treatment of HPV-associated lesions.
Snoeck R; Andrei G; De Clercq E
Verh K Acad Geneeskd Belg; 2001; 63(2):93-120, discussion 120-2. PubMed ID: 11436421
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells.
Andrei G; Snoeck R; Schols D; De Clercq E
Oncol Res; 2000; 12(9-10):397-408. PubMed ID: 11697818
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
Wei XM; Wang Q; Gao SJ; Sui L
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
[TBL] [Abstract][Full Text] [Related]
9. Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.
Mertens B; Nogueira T; Stranska R; Naesens L; Andrei G; Snoeck R
Oncotarget; 2016 Jul; 7(30):47302-47318. PubMed ID: 27331622
[TBL] [Abstract][Full Text] [Related]
10. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
12. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
13. Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir.
Catalani S; Palma F; Battistelli S; Nuvoli B; Galati R; Benedetti S
Toxicol In Vitro; 2017 Jun; 41():49-55. PubMed ID: 28223140
[TBL] [Abstract][Full Text] [Related]
14. 3-(2-Chloropropyl amide)-4-methoxy-N-phenylbenzamide inhibits expression of HPV oncogenes in human cervical cancer cell.
Han F; Li Y; Lu Q; Ma L; Wang H; Jiang J; Li Z; Li Y
Virol J; 2017 Jul; 14(1):145. PubMed ID: 28754129
[TBL] [Abstract][Full Text] [Related]
15. Novel action modality of the diterpenoid anisomelic acid causes depletion of E6 and E7 viral oncoproteins in HPV-transformed cervical carcinoma cells.
Paul P; Rajendran SK; Peuhu E; Alshatwi AA; Akbarsha MA; Hietanen S; Eriksson JE
Biochem Pharmacol; 2014 May; 89(2):171-84. PubMed ID: 24565908
[TBL] [Abstract][Full Text] [Related]
16. [Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells].
Liu J; Liu J; Li SZ; Zheng YA; Guo SY; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):475-481. PubMed ID: 28446399
[TBL] [Abstract][Full Text] [Related]
17. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
18. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
19. Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells.
Yang Z; Liu Z; Ablise M; Maimaiti A; Aihaiti A; Alimujiang Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067428
[TBL] [Abstract][Full Text] [Related]
20. Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells.
Clemente-Soto AF; Salas-Vidal E; Milan-Pacheco C; Sánchez-Carranza JN; Peralta-Zaragoza O; González-Maya L
Mol Med Rep; 2019 Mar; 19(3):2097-2106. PubMed ID: 30664221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
